Literature DB >> 29178965

A child with distal (type 1) renal tubular acidosis presenting with progressive gross motor developmental regression and acute paralysis.

Randula Ranawaka1, Kavinda Dayasiri2, Manoji Gamage3.   

Abstract

BACKGROUND: Distal (Type 1) renal tubular acidosis (dRTA) is characterized by inability to secrete hydrogen irons from the distal tubule. The aetiology of dRTA is diverse and can be either inherited or acquired. Common clinical presentations of dRTA in the paediatric age group include polyuria, nocturia, failure to thrive, constipation, abnormal breathing and nephrolithiasis. Though persistent hypokalemia is frequently seen in dRTA, hypokalemic muscular paralysis is uncommon and rarely described in children. CASE
PRESENTATION: Three and a half years old girl was referred for evaluation of progressive loss of gross motor milestones over 6 months and acute episode of paralysis. Her other developmental domains were age appropriate. Notably, there was no history of polyuria, polydipsia, nocturia and abnormal breathing. Physical examination revealed proximal myopathy (waddling gait and positive Gower's sign), diminished lower limb reflexes and muscle tone. Her serum potassium was low (2.1 meq/l) and she was subsequently investigated for hypokalemic paralysis. Diagnosis of distal renal tubular acidosis was made, based on hypokalemic hyperchloremic metabolic acidosis with normal anion gap, high urine pH, borderline hypercalciuria, medullary nephrocalcinosis and exclusion of other differential diagnosis. The child showed complete symptomatic recovery upon commencement of standard treatment for distal renal tubular acidosis.
CONCLUSIONS: This case report highlights the importance of considering hypokalemia and renal tubular acidosis in the differential diagnosis of acute flaccid paralysis and proximal myopathy. Early diagnosis will prevent costly investigations and enable rapid clinical recovery in the affected child.

Entities:  

Keywords:  Acute flaccid paralysis; Distal (type 1) renal tubular acidosis; Hypokalemia; Proximal myopathy

Mesh:

Year:  2017        PMID: 29178965      PMCID: PMC5702097          DOI: 10.1186/s13104-017-2949-2

Source DB:  PubMed          Journal:  BMC Res Notes        ISSN: 1756-0500


Background

Distal (Type 1) renal tubular acidosis (dRTA) is characterized by inability to secrete hydrogen irons from the distal tubule. It was first described in 1946 [1] and characterized by a clinical syndrome consisting of hypokalemic, hyperchloremic metabolic acidosis with normal anion gap, high urine pH (> 5.5), nephrocalcinosis and nephrolithiasis [2]. The aetiology of dRTA is diverse and can be either inherited or acquired. The genetic basis of dRTA was described recently as a defect in urinary excretion of ammonium [3]. Common clinical presentations of dRTA in the paediatric age group include polyuria, failure to thrive, constipation, abnormal breathing and nephrolithiasis. Though persistent hypokalemia is frequently seen in dRTA, hypokalemic muscular paralysis is uncommon and rarely described in children [4]. This case report has described a child with distal (type 1) renal tubular acidosis who presented with gross motor developmental regression and acute episode of paralysis.

Case presentation

Three and a half years old girl was referred for evaluation of progressive loss of gross motor milestones over 6 months and acute episode of paralysis. She was first born to healthy non-consanguineous parents and without family history of motor developmental disorders. Parents were concerned by progressively worsening of difficulty in walking, climbing and standing from sitting position. Her other developmental domains were age appropriate. Notably, there was no history of polyuria, polydipsia and rapid breathing. Physical examination revealed proximal myopathy (waddling gait and positive Gower’s sign), diminished knee reflex and reduced muscle tone. Initial investigations revealed normal serum creatine phosphokinase (89 U/l), TSH (thyroid stimulating hormone) (3.73 µIU/ml), electromyogram and nerve conduction studies. She also had normal serum calcium (2.3 mmol/l), magnesium (0.8 mmol/l), lactate (0.57 mmol/l) and ammonia (47 µg/dl). Muscle biopsy was suggestive of non-specific myopathy and did not reveal red ragged fibers, mitochondrial disruption and necrosis. MRI brain and spine showed normal findings. Her serum potassium was low (2.1 meq/l) and she was subsequently investigated for hypokalemic paralysis. Venous blood gases showed metabolic acidosis (pH − 7.3, HCO3− 19 meq/l) with a normal anion gap (8 meq/l). Urine pH was 6.5. Urine was negative for reducing substances and protein. Renal ultrasound revealed bilateral nephrocalcinosis. Serum creatinine (32 µmol/l) was normal. She had hyperchloremia (serum chloride—113 meq/l). Urine calcium/creatinine ratio was high (0.72 mmol/mmol). Tubular resorption of phosphate was normal (> 80%). Diagnosis of distal renal tubular acidosis was made, based on hypokalemic hyperchloremic metabolic acidosis with normal anion gap, high urine pH, hypercalciuria, medullary nephrocalcinosis and exclusion of other differential diagnosis. The child showed complete symptomatic recovery and achieved all age appropriate gross motor milestones upon commencement of standard treatment, poly-citra for distal renal tubular acidosis.

Discussion and conclusions

Distal renal tubular acidosis in children is mostly hereditary [5]. It can however, occur secondary to obstructive uropathies, drugs and toxin exposure, and autoimmune diseases [6]. Potassium depletion in dRTA can be secondary to number of genetic defect in cellular metabolism manifested as autosomal dominant or recessive [7] condition. dRTA in the paediatric age group commonly presents with polyuria, constipation, failure to thrive and nephrolithiasis. Hypokalemic paralysis and progressive weakness are rare manifestations reported in children [8] and data on incidence are not available in literature [5]. Hypokalemic paralysis had been periodic in several reported cases of dRTA [9]. Progressive proximal myopathy as the presentation of hypokalemia in dRTA is very unusual and had been previously reported in association with polymyositis [10]. The unusual presentation was misinterpreted in the initial stage as a primary neuromuscular disorder and the diagnosis was revealed only after extended evaluation. Limited literature has indicated that this atypical presentation can always be misinterpreted as a neurological disorder highlighting the importance of the need of initial evaluation with serum electrolytes [4]. Levels of calcium and phosphate are usually normal in dRTA. However, rickets is common in untreated dRTA because of bone resorption to buffer chronic metabolic acidosis [11]. Mortality following hypokalemic paralysis is secondary to respiratory failure and cardiac arrhythmias [8]. Management of dRTA includes alkali and potassium replacement along with the treatment of the underlying disorder. This case report highlights the importance of considering hypokalemia and renal tubular acidosis in the differential diagnosis of acute flaccid paralysis and proximal myopathy. Early diagnosis will prevent costly investigations and enable rapid clinical recovery in the affected child.
  10 in total

Review 1.  Hereditary distal renal tubular acidosis: new understandings.

Authors:  D Batlle; H Ghanekar; S Jain; A Mitra
Journal:  Annu Rev Med       Date:  2001       Impact factor: 13.739

Review 2.  Renal tubular acidosis: the clinical entity.

Authors:  Juan Rodríguez Soriano
Journal:  J Am Soc Nephrol       Date:  2002-08       Impact factor: 10.121

Review 3.  Approach to renal tubular disorders.

Authors:  Arvind Bagga; Anurag Bajpai; Shina Menon
Journal:  Indian J Pediatr       Date:  2005-09       Impact factor: 1.967

Review 4.  Hypokalemic paralyses: a review of the etiologies, pathophysiology, presentation, and therapy.

Authors:  R E Stedwell; K M Allen; L S Binder
Journal:  Am J Emerg Med       Date:  1992-03       Impact factor: 2.469

5.  A case report and review of hypokalemic paralysis secondary to renal tubular acidosis.

Authors:  Nilzete Liberato Bresolin; Eugênio Grillo; Vera Regina Fernandes; Francisca Lígia Cirilo Carvalho; José Eduardo Coutinho Goes; Ronaldo José Melo da Silva
Journal:  Pediatr Nephrol       Date:  2005-03-17       Impact factor: 3.714

6.  Sporadic distal renal tubular acidosis and periodic hypokalaemic paralysis in Kashmir.

Authors:  P A Koul; S M Saleem; D Bhat
Journal:  J Intern Med       Date:  1993-06       Impact factor: 8.989

7.  The effects of chronic acid loads in normal man: further evidence for the participation of bone mineral in the defense against chronic metabolic acidosis.

Authors:  J Lemann; J R Litzow; E J Lennon
Journal:  J Clin Invest       Date:  1966-10       Impact factor: 14.808

8.  Renal tubular acidosis complicated with hypokalemic periodic paralysis.

Authors:  Y C Chang; C C Huang; Y Y Chiou; C Y Yu
Journal:  Pediatr Neurol       Date:  1995-07       Impact factor: 3.372

Review 9.  Distal renal tubular acidosis: a hereditary disease with an inadequate urinary H⁺ excretion.

Authors:  Laura Escobar; Natalia Mejía; Helena Gil; Fernando Santos
Journal:  Nefrologia       Date:  2013-03-12       Impact factor: 2.033

10.  Osteomalacia and late rickets; the various etiologies met in the United States with emphasis on that resulting from a specific form of renal acidosis, the therapeutic indications for each etiological sub-group, and the relationship between osteomalacia and Milkman's syndrome.

Authors:  F ALBRIGHT; C H BURNETT
Journal:  Medicine (Baltimore)       Date:  1946-12       Impact factor: 1.889

  10 in total
  2 in total

Review 1.  Distal renal tubular acidosis: genetic causes and management.

Authors:  Sílvia Bouissou Morais Soares; Luiz Alberto Wanderley de Menezes Silva; Flávia Cristina de Carvalho Mrad; Ana Cristina Simões E Silva
Journal:  World J Pediatr       Date:  2019-05-11       Impact factor: 2.764

2.  Isolation, Characterization, And High Throughput Extracellular Flux Analysis of Mouse Primary Renal Tubular Epithelial Cells.

Authors:  Wen Ding; Keyvan Yousefi; Lina A Shehadeh
Journal:  J Vis Exp       Date:  2018-06-20       Impact factor: 1.355

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.